Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
On CNBC's "Mad Money Lightning Round," Jim Cramer said Oneok (NYSE:OKE) is "terrific" and recommended buying more of the stock.
在CNBC的“疯狂金钱闪电战”上，吉姆·克雷默表示Oneok（纽交所：OKE）非常出色，建议购买更多股票。
On Aug. 5, ONEOK reported better-than-expected second-quarter GAAP EPS results, posting quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.21 per share.
8月5日，ONEOk报告了超预期的第二季度GAAP每股收益结果，季度收益为1.33美元，超过分析师共识预估的1.21美元每股收益。
"The problem with Dollar Tree (NASDAQ:DLTR) is that people I think have discovered that the small form is no longer working, they would rather go to Walmart (NYSE:WMT), which is a buy, or Costco (NASDAQ:COST) if they can afford the membership fee," he said.
他说：“美元树（纳斯达克：DLTR）的问题在于，人们发现小型形式不再起作用，他们宁愿去沃尔玛（纽交所：WMT），这是一款买入的股票，或者如果能负担得起会员费，则去好市多（纳斯达克：COST）。”
On July 16, Piper Sandler analyst Peter Keith downgraded the rating for Dollar Tree from Overweight to Neutral and lowered the price target from $143 to $112.
7月16日，派杰投资分析师彼得·基思将美元树的评级从超重调降至中立，并将目标价从143美元下调至112美元。
The "Mad Money" host recommended staying away from Dexcom, Inc. (NASDAQ:DXCM). "Dexcom had a real bad miss. They still really haven't fully explained why that is," he noted.
“疯狂金钱”主持人建议远离德康医疗（纳斯达克：DXCM）。“德康医疗错失了真正的机会，他们仍然没有充分解释为什么，”他指出。
Dexcom specializes in selling continuous glucose monitors.
德康医疗专业销售连续血糖监测仪。
On Aug. 5, Baird analyst Jeff Johnson downgraded the company from Outperform to Neutral and slashed the price target from $161 to $80.
8月5日，贝尔德分析师杰夫·约翰逊将该公司的评级从超越市场调整为中立，并将目标价从161美元下调至80美元。
When asked about KeyCorp (NYSE:KEY), he said, "Definitely keep Key. Key is very, very strong, a terrific, terrific bank."
在谈到KeyCorp（纽交所：KEY）时，他说：“绝对可以持有Key。Key银行非常非常强大。”
Cramer said he would be a buyer of CRISPR Therapeutics AG (NASDAQ:CRSP).
克雷默表示他将成为crispr therapeutics股份公司（纳斯达克：CRSP）的买家。
On Aug. 5, CRISPR Therapeutics posted a narrower-than-expected quarterly loss.
8月5日，crispr therapeutics发布了比预期略窄的季度亏损。
Price Action:
价格行动：
- Dollar Tree shares fell 1.6% to settle at $95.03 on Wednesday.
- Oneok shares rose 0.9% to close at $83.06.
- Dexcom shares fell 7.8% to close at $69.32.
- CRISPR shares fell 4.2% to settle at $47.27 on Wednesday.
- Palo Alto shares rose 2.6% to close at $301.93 on Tuesday.
- 美元树股价下跌1.6％，收于95.03美元。
- Oneok股价上涨0.9％，收于83.06美元。
- 德康医疗股价下跌7.8％，收于69.32美元。
- CRISPR股价下跌4.2％，收于47.27美元。
- Palo Alto股价上涨2.6％，收于301.93美元。
- Wall Street's Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields
- 华尔街最准确的分析师对三只消费股票的高股息收益率进行评估